AcelRx Pharma (ACRX) Misses Q4 EPS by 6c
Tweet
Share
E-mail
Get Alerts ACRX Hot Sheet
Join SI Premium – FREE
AcelRx Pharma (NASDAQ: ACRX) reported Q4 EPS of ($0.06), $0.06 worse than the analyst estimate of $0.00.
For earnings history and earnings-related data on AcelRx Pharma (ACRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
